Menstrual blood‐derived mesenchymal stem cells attenuate inflammation and improve the mortality of acute liver failure combining with A2AR agonist in mice

BACKGROUND AND AIM: Acute liver failure (ALF) poses a serious public health issue. The menstrual blood‐derived mesenchymal stem cells (MenSCs) have been applied to cure various liver‐related diseases. However, the efficacy and mechanism are far from clear. This study aims to explore the efficacy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Dazhi, Zeng, Ruichao, Teng, Guigen, Cai, Chao, Pan, Tongtong, Tu, Hanxiao, Lin, Hongwei, Du, Qingjing, Wang, Huahong, Chen, Yongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Experimental Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518829/
https://www.ncbi.nlm.nih.gov/pubmed/33729623
http://dx.doi.org/10.1111/jgh.15493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518829/
https://www.ncbi.nlm.nih.gov/pubmed/33729623
http://dx.doi.org/10.1111/jgh.15493

Ejemplares similares